Literature DB >> 31625096

Isolation of Antigen-Specific VHH Single-Domain Antibodies by Combining Animal Immunization with Yeast Surface Display.

Lukas Roth1, Simon Krah1, Janina Klemm1, Ralf Günther1, Lars Toleikis1, Michael Busch2, Stefan Becker1, Stefan Zielonka3.   

Abstract

In addition to conventional hetero-tetrameric antibodies, the adaptive immune repertoire of camelids comprises the so-called heavy chain-only antibodies devoid of light chains. Consequently, antigen binding is mediated solely by the variable domain of the heavy chain, referred to as VHH. In recent years, these single-domain moieties emerged as promising tools for biotechnological and biomedical applications. In this chapter, we describe the generation of VHH antibody yeast surface display libraries from immunized Alpacas and Lamas as well as the facile isolation of antigen-specific molecules in a convenient fluorescence-activated cell sorting (FACS)-based selection process.

Entities:  

Keywords:  Antibody engineering; Camelid antibodies; Protein engineering; Single-domain antibodies; VHH (variable domain of the heavy chain of heavy chain-only antibodies); Yeast surface display

Mesh:

Substances:

Year:  2020        PMID: 31625096     DOI: 10.1007/978-1-4939-9853-1_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  In vitro inhibition of cancer angiogenesis and migration by a nanobody that targets the orphan receptor Tie1.

Authors:  May Meltzer; Noam Eliash; Ziv Azoulay; Uzi Hadad; Niv Papo
Journal:  Cell Mol Life Sci       Date:  2022-05-23       Impact factor: 9.261

2.  Biophysical and biochemical characterization of a VHH-based IgG-like bi- and trispecific antibody platform.

Authors:  Lukas Pekar; Michael Busch; Bernhard Valldorf; Steffen C Hinz; Lars Toleikis; Simon Krah; Stefan Zielonka
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

3.  Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their Engineered CDR-H3-Only Knobbody Counterparts Targeting Epidermal Growth Factor Receptor Elicit Potent NK Cell-Mediated Cytotoxicity.

Authors:  Lukas Pekar; Daniel Klewinghaus; Paul Arras; Stefania C Carrara; Julia Harwardt; Simon Krah; Desislava Yanakieva; Lars Toleikis; Vaughn V Smider; Harald Kolmar; Stefan Zielonka
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561

Review 4.  Recombinant expression of nanobodies and nanobody-derived immunoreagents.

Authors:  Ario de Marco
Journal:  Protein Expr Purif       Date:  2020-04-11       Impact factor: 1.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.